Proven Ovarian Cancer Patient Recruitment Results
Our specialized ovarian cancer recruitment platform delivers faster enrollment across all stages and molecular subtypes.
Comprehensive Ovarian Cancer Patient Recruitment
Expert recruitment across all ovarian cancer subtypes and treatment lines for accelerated clinical trial enrollment.
BRCA-Mutant Ovarian Cancer
Specialized recruitment for BRCA1/2 mutation carriers requiring PARP inhibitor and targeted therapies
Platinum-Resistant Ovarian Cancer
Advanced platinum-resistant disease recruitment for novel therapies and combination studies
High-Grade Serous Ovarian Cancer
Most common ovarian cancer subtype recruitment across all treatment lines and stages
Newly Diagnosed Ovarian Cancer
First-line treatment recruitment for maintenance therapy and combination treatment trials
Recurrent Ovarian Cancer
Relapsed disease recruitment for second-line and beyond treatment studies
Clear Cell Ovarian Cancer
Rare ovarian cancer subtype recruitment for specialized treatment and targeted therapies
Advanced Ovarian Cancer Recruitment Strategies
Multi-channel approach combining digital outreach, gynecologic oncology networks, and patient advocacy partnerships.
Digital Patient Outreach
Targeted campaigns reaching ovarian cancer patients through social media, search marketing, and patient portals
Gynecologic Oncology Networks
Direct relationships with gynecologic oncologists, women's cancer centers, and specialty practices
Patient Advocacy Collaboration
Partnerships with ovarian cancer foundations, support groups, and women's health organizations
Genetic Testing Coordination
BRCA1/2, homologous recombination deficiency testing for precision recruitment